Allarity Therapeutics Files 8-K
Ticker: ALLR · Form: 8-K · Filed: Feb 25, 2025 · CIK: 1860657
Sentiment: neutral
Topics: 8-k, filing, corporate-event
Related Tickers: ALLR
TL;DR
ALLR filed an 8-K on Feb 25 for an event on Feb 24 - check for updates.
AI Summary
Allarity Therapeutics, Inc. filed an 8-K on February 25, 2025, reporting an event that occurred on February 24, 2025. The filing indicates "Other Events" and "Financial Statements and Exhibits" as key items. The company is incorporated in Delaware and headquartered in Boston, MA.
Why It Matters
This 8-K filing signals a material event or update from Allarity Therapeutics, Inc. that investors and stakeholders should be aware of.
Risk Assessment
Risk Level: low — This filing is a standard 8-K reporting an event and does not inherently indicate significant risk.
Key Players & Entities
- Allarity Therapeutics, Inc. (company) — Registrant
- February 24, 2025 (date) — Date of earliest event reported
- February 25, 2025 (date) — Date of report
- Boston, MA (location) — Principal executive offices
FAQ
What specific event triggered this 8-K filing?
The filing indicates 'Other Events' and 'Financial Statements and Exhibits' as item information, but the specific event is not detailed in the provided text.
When was the earliest event reported in this filing?
The earliest event reported was on February 24, 2025.
What is the exact name of the registrant?
The exact name of the registrant is Allarity Therapeutics, Inc.
Where are Allarity Therapeutics, Inc.'s principal executive offices located?
The principal executive offices are located at 24 School Street, 2nd Floor, Boston, MA 02108.
What is the SEC file number for Allarity Therapeutics, Inc.?
The SEC file number is 001-41160.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 25, 2025 regarding Allarity Therapeutics, Inc. (ALLR).